The Abortion Pill Is Legal Again — For Now. Here's What's Actually Happening.
The Supreme Court temporarily restored mail access to mifepristone on Monday. You have one week before this fight resurfaces. This is what you need to understand about what just happened and what comes next.
By The New Brief Politics Desk | May 5, 2026
On Monday, the Supreme Court temporarily restored nationwide access to mifepristone — the abortion pill used in the majority of abortions in the United States — blocking a lower court ruling that would have required in-person doctor visits to obtain it. The stay lasts one week. After that, the fight resumes.
Here is what happened, in order, because the sequencing matters.
The Sequence
Last Friday, a federal appeals court ruled that the FDA must revert to older, more restrictive rules around mifepristone — specifically, that the drug can only be prescribed after an in-person appointment, not via telehealth, and cannot be mailed to patients. The ruling came in a case brought by the state of Louisiana challenging the FDA's decision years ago to allow telehealth prescriptions and mail delivery of the drug.
If the appeals court ruling had gone into effect immediately, millions of people across the country would have lost access to medication abortion overnight. The ability to consult a doctor online and receive the pill by mail has become, since Dobbs, one of the primary ways people in states with abortion restrictions access the procedure — by crossing a legal boundary that exists in cyberspace rather than in geography.
On Monday, Justice Samuel Alito — yes, the author of the Dobbs decision — signed an administrative stay blocking the appeals court ruling from taking effect. The stay lasts until May 11. By Thursday, May 7, all parties must file legal briefs. The full Court will then decide whether to extend the stay or let the appeals court ruling take effect while the underlying case is litigated.
"The stay keeps access open for now. But Alito signing it is not a signal of where he stands on the merits — administrative stays are procedural. Read nothing into the authorship."
What Is Mifepristone and Why Does It Matter This Much
Mifepristone, taken in combination with misoprostol, is the standard two-drug regimen for medication abortion. It is used in roughly two-thirds of all abortions in the United States. It has been FDA-approved for over two decades. The medical and scientific consensus on its safety is not in serious dispute — the FDA's own data and decades of clinical evidence support its approval.
The legal battle over mifepristone is not really about the drug's safety. It is about whether anti-abortion states and advocacy groups can use federal courts to impose restrictions that go beyond what individual state legislatures have passed — and whether they can effectively override federal agency decisions on drug approval. If they succeed, the implications extend well beyond abortion: the precedent would allow courts to second-guess FDA approvals of any drug that politically organized groups oppose.
What Comes Next
The Supreme Court will decide by May 11 whether to extend the stay. If it does, the case continues to be litigated and mail access remains intact for now. If it doesn't, the appeals court restriction takes effect immediately — and millions of people lose access to telehealth abortion prescriptions overnight.
Watch the vote count when that decision comes. A five-justice majority would be required to let the restriction take effect. Given the Court's current composition, that majority is possible. What Monday's stay tells us is only that the Court wanted more time and more briefing — not how it will ultimately rule.
For anyone who uses or relies on access to medication abortion: nothing has changed as of today. The pill remains accessible through telehealth and by mail. What changes, potentially, is May 11. Mark the date.
— The New Brief | May 5, 2026 —
